SCHEMBL2457418

SCHEMBL2457418

O=c1c(Cc2ccc(Cl)c(Cl)c2)c(C2CCC2)[nH]c2ncnn12

nearest known ligand 0.42

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
CCR2 P41597 2/20 0.42
CCR5 P51681 2/20 0.42
PDE2A O00408 10/20 0.41
PLAT P00750 1/20 0.37
NR3C1 P04150 2/20 0.35
ALKBH3 Q96Q83 2/20 0.35
ATM Q13315 1/20 0.33
PDE1B Q01064 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2454917 0.91 PDE2A (0.44) CCR2CCR5PDE2ANR3C1PDE1B
SCHEMBL2454681 0.91 PDE2A (0.44) CCR2CCR5PDE2APLATNR3C1
SCHEMBL2456756 0.88 PDE2A (0.46) PDE2ANR3C1
SCHEMBL2460219 0.87 CCR2 (0.46) CCR2CCR5PDE2APLATNR3C1
SCHEMBL2465875 0.87 NR3C1 (0.33) PDE2ANR3C1
SCHEMBL2456944 0.85 PDE2A (0.41) PDE2ANR3C1PDE1B
SCHEMBL2456663 0.84 CCR2 (0.48) CCR2CCR5PDE2APLATNR3C1
SCHEMBL2464957 0.82 NR3C1 (0.33) CCR2CCR5PDE2ANR3C1
SCHEMBL2460011 0.82 CCR2 (0.43) CCR2CCR5PDE2ANR3C1
SCHEMBL2455160 0.82 CCR2 (0.43) CCR2PDE2ANR3C1PDE1B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011114148-A1 4H- [1, 2, 4] TRIAZOLO [5, 1 -B] PYRIMIDIN-7 -ONE DERIVATIVES AS CCR2B RECEPTOR ANTAGONISTS ASTRAZENECA AB (SE) 2011-09-22 WO claimed
WO-2011114148-A1 4H- [1, 2, 4] TRIAZOLO [5, 1 -B] PYRIMIDIN-7 -ONE DERIVATIVES AS CCR2B RECEPTOR ANTAGONISTS ASTRAZENECA AB (SE) 2011-09-22 WO disclosed
WO-2011114148-A1 4H- [1, 2, 4] TRIAZOLO [5, 1 -B] PYRIMIDIN-7 -ONE DERIVATIVES AS CCR2B RECEPTOR ANTAGONISTS ASTRAZENECA AB (SE) 2011-09-22 WO disclosed